Alopecia

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients…

LOS ANGELES, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The Global Alopecia Market Size accounted for USD 8,379 Million in 2021 and is estimated to achieve a market size of USD 16,760 Million by 2030 growing at a CAGR of 8.2% from 2022 to 2030.…